Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom

Pearson, I., Hawe, E., Zuluaga Sanchez, S., Wolowacz, S., & Haiderali, A. (2015). Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom. Value in Health, 18(7), A455. https://doi.org/10.1016/j.jval.2015.09.1159

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Use of a web-based portal to return normal individual research results in Early Check
Article

The importance of quality data to track global progress in addressing stillbirths and neonatal mortality
Article

Pre-natal exposure to NO2 and PM2.5 and newborn lung function